Profit

Sun Pharma May Test Rs 760-780 on Downside: Aditya Agarwal

PUBLISHED ON: March 28, 2016 | Duration: 5 min, 46 sec

facebooktwitteremailkoo
loading..
Aditya Agarwal, head technical research at Way2wealth, says Sun Pharma has closed below a crucial support at Rs 820 and selling pressure in the stock may continue going ahead. The shares may test Rs 780 levels in the short term, he adds.
ALSO WATCH
BJP के 400 से ज्यादा उम्मीदवार तय, कितने बाहरियों को मौका, कितने का कटा टिकट | Hot Topic

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com